Summary: antibody therapy with rituximab.
Although rituximab has gained increasing
use in the therapy of extranodal marginal
zone lymphomas of MALT type, the
curative potential of this modality is
unknown. Further studies are necessary
to advance our understanding of the role
of antibiotic or antiviral therapy for this
Competing interests: None.
Br J Ophthalmol 2008;92:446448.
1. Coupland SE, Damato B. Lymphomas involving the
eye and the ocular adnexa. Curr Opin Ophthalmol
2. Isaacson P, Wright DH. Malignant lymphoma of
mucosa-associated lymphoid tissue. A distinctive type
of B-cell lymphoma. Cancer 1983;52:14106.
3. Suarez F, Lortholary O, Hermine O, et al. Infection-